The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Open accessAbstract
During the last century, there has been an increasing prevalence of hyperuricaemia noted in many populations. While uric acid is usually discussed in the context of gout, hyperuricaemia is also associated with hypertension, chronic kidney disease, hypertriglyceridaemia, obesity, atherosclerotic heart disease, metabolic syndrome, and type 2 diabetes. Here we review the connection between hyperuricaemia and cardiovascular, kidney and metabolic diseases. Contrary to the popular view that uric acid is an inert metabolite of purine metabolism, recent studies suggest serum uric acid may have a variety of pro-inflammatory, pro-oxidative and vasoconstrictive actions that may contribute to cardiometabolic diseases. Hyperuricaemia is a predictive factor for the development of hypertension, metabolic syndrome, type 2 diabetes, coronary artery disease, left ventricular hypertrophy, atrial fibrillation, myocardial infarction, stroke, heart failure and chronic kidney disease. Treatment with uric acid-lowering therapies has also been found to improve outcomes in patients with hypertension and kidney disease, in some but not all studies. In conclusion, uric acid is emerging as a potentially treatable risk factor for cardiometabolic diseases, and more clinical trials investigating the potential benefit of lowering serum uric acid are recommended in individuals with hyperuricaemia with and without deposition and concomitant hypertension, metabolic syndrome or chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhu, Y., Pandya, B. J., & Choi, H. K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30520 · Cited by 1,785
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Self-citationSerum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Feig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Self-citationCardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Self-citationHyperuricemia and incident hypertension: A systematic review and meta‐analysis
Grayson, P. C., Kim, S. Y., LaValley, M., & Choi, H. K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20344 · Cited by 756
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Lanaspa, M. A., Sanchez-Lozada, L. G., Choi, Y.-J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C. A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399899 · Cited by 710
Self-citationKolz, M., Johnson, T., Sanna, S., Teumer, A., Vitart, V., Perola, M., Mangino, M., Albrecht, E., Wallace, C., Farrall, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000504 · Cited by 658
Elevated Uric Acid Increases the Risk for Kidney Disease
Obermayr, R. P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., & Klauser-Braun, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010080 · Cited by 647
Yu, M.-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D.-H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337da1d · Cited by 626
Self-citationUric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2006) · Stroke · doi:10.1161/01.str.0000221716.55088.d4 · Cited by 615
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Risk Factors for End-Stage Renal Disease: 25-Year Follow-up
Hsu, C.-Y., Iribarren, C., McCulloch, C. E., Darbinian, J., & Go, A. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.605 · Cited by 589
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Self-citationAssociation Between Serum Uric Acid and Development of Type 2 Diabetes
Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., Saito, A., & Sone, H. (2009) · Diabetes Care · doi:10.2337/dc09-0288 · Cited by 549
Hyperuricemia in Childhood Primary Hypertension
Feig, D. I., & Johnson, R. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000085858.66548.59 · Cited by 535
Self-citationSignificance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00934-5 · Cited by 526
Hyperuricemia in Primary and Renal Hypertension
Cannon, P. J., Stason, W. B., Demartini, F. E., Sommers, S. C., & Laragh, J. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609012750902 · Cited by 505
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Definition of hyperuricemia and gouty conditions
Bardin, T., & Richette, P. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000028 · Cited by 499
Serum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
Self-citationUric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease
Kanellis, J., & Kang, D.-H. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.007 · Cited by 443
Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., Coyfish, M., Guillo, S., Jansen, T., Janssens, H., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215315 · Cited by 440
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
MAXWELL, S. R. J., THOMASON, H., SANDLER, D., LEGUEN, C., BAXTER, M. A., THORPE, G. H. G., JONES, A. F., & BARNETT, A. H. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1390687.x · Cited by 403
Impact of Oxypurinol in Patients With Symptomatic Heart Failure
Hare, J. M., Mangal, B., Brown, J., Fisher, C., Freudenberger, R., Colucci, W. S., Mann, D. L., Liu, P., Givertz, M. M., & Schwarz, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.068 · Cited by 392
Rao, G. N., Corson, M. A., & Berk, B. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93017-6 · Cited by 391
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Lv, Q., Meng, X.-F., He, F.-F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X.-J., Liu, J.-S., Zhu, Z.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056864 · Cited by 364
Uric acid and the development of metabolic syndrome in women and men
Sui, X., Church, T. S., Meriwether, R. A., Lobelo, F., & Blair, S. N. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.030 · Cited by 352
Perez-Pozo, S. E., Schold, J., Nakagawa, T., Sánchez-Lozada, L. G., Johnson, R. J., & Lillo, J. L. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.259 · Cited by 344
Self-citationWang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114259 · Cited by 341
URic Acid and Risk Of Heart Failure: A Systematic Review and Meta-Analysis
Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., & Wang, J. (2014) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft132 · Cited by 339
Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents
Soletsky, B., & Feig, D. I. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196980 · Cited by 334
Yang, Q., Köttgen, A., Dehghan, A., Smith, A. V., Glazer, N. L., Chen, M.-H., Chasman, D. I., Aspelund, T., Eiriksdottir, G., Harris, T. B., et al. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.109.934455 · Cited by 320
Sircar, D., Chatterjee, S., Waikhom, R., Golay, V., Raychaudhury, A., Chatterjee, S., & Pandey, R. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.017 · Cited by 314
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia
Sánchez-Lozada, L. G., Soto, V., Tapia, E., Avila-Casado, C., Sautin, Y. Y., Nakagawa, T., Franco, M., Rodríguez-Iturbe, B., & Johnson, R. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00104.2008 · Cited by 312
Self-citationGivertz, M. M., Anstrom, K. J., Redfield, M. M., Deswal, A., Haddad, H., Butler, J., Tang, W. H. W., Dunlap, M. E., LeWinter, M. M., Mann, D. L., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014536 · Cited by 296
Serum Uric Acid and Risk of Coronary Heart Disease
Moriarity, J. T., Folsom, A. R., Iribarren, C., Nieto, F. J., & Rosamond, W. D. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00037-x · Cited by 280
Lanaspa, M. A., Sanchez-Lozada, L. G., Cicerchi, C., Li, N., Roncal-Jimenez, C. A., Ishimoto, T., Le, M., Garcia, G. E., Thomas, J. B., Rivard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047948 · Cited by 280
Self-citationZoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Effect of Oestrogen Therapy on Plasma and Urinary Levels of Uric Acid
Nicholls, A., Snaith, M. L., & Scott, J. T. (1973) · BMJ · doi:10.1136/bmj.1.5851.449 · Cited by 272
Trifirò, G., Morabito, P., Cavagna, L., Ferrajolo, C., Pecchioli, S., Simonetti, M., Bianchini, E., Medea, G., Cricelli, C., Caputi, A. P., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201254 · Cited by 272
Wheeler, J. G., Juzwishin, K. D. M., Eiriksdottir, G., Gudnason, V., & Danesh, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020076 · Cited by 267
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A., & Timio, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.019 · Cited by 260
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kadioglu, G. K., Kirbas, I., Duranay, M., Covic, A., & Johnson, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11451210 · Cited by 248
Self-citationMiao, Z., Li, C., Chen, Y., Zhao, S., Wang, Y., Wang, Z., Chen, X., Xu, F., Wang, F., Sun, R., et al. (2008) · PubMed · Cited by 247
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
Feig, D. I., Nakagawa, T., Ananth Karumanchi, S., Oliver, W. J., Kang, D.-H., Finch, J., & Johnson, R. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00729.x · Cited by 240
Self-citationHyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies
Li, M., Hou, W., Zhang, X., Hu, L., & Tang, Z. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.051 · Cited by 222
Ficociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218
Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review
Thangaratinam, S., Ismail, K., Sharp, S., Coomarasamy, A., & Khan, K. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00908.x · Cited by 210
Domrongkitchaiporn, S., Sritara, P., Kitiyakara, C., Stitchantrakul, W., Krittaphol, V., Lolekha, P., Cheepudomwit, S., & Yipintsoi, T. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030208 · Cited by 209
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Sato, Y., Feig, D. I., Stack, A. G., Kang, D.-H., Lanaspa, M. A., Ejaz, A. A., Sánchez-Lozada, L. G., Kuwabara, M., Borghi, C., & Johnson, R. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0174-z · Cited by 199
Self-citationCounteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez-Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 193
Self-citationOgino, K., Kato, M., Furuse, Y., Kinugasa, Y., Ishida, K., Osaki, S., Kinugawa, T., Igawa, O., Hisatome, I., Shigemasa, C., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.868604 · Cited by 190
Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243634 · Cited by 187
Self-citationSerum Uric Acid and Target Organ Damage in Primary Hypertension
Viazzi, F., Parodi, D., Leoncini, G., Parodi, A., Falqui, V., Ratto, E., Vettoretti, S., Bezante, G. P., Del Sette, M., Deferrari, G., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000161184.10873.ea · Cited by 175
Takir, M., Kostek, O., Ozkok, A., Elcioglu, O. C., Bakan, A., Erek, A., Mutlu, H. H., Telci, O., Semerci, A., Odabas, A. R., et al. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000242 · Cited by 174
Self-citationEffect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis
Agarwal, V., Hans, N., & Messerli, F. H. (2013) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00701.x · Cited by 173
Cicero, A. F. G., Salvi, P., D’Addato, S., Rosticci, M., & Borghi, C. (2014) · Journal of Hypertension · doi:10.1097/hjh.0b013e328365b916 · Cited by 170
Self-citationHyperuricemia as a Predictor of Hypertension in a Screened Cohort in Okinawa, Japan
NAGAHAMA, K., INOUE, T., ISEKI, K., TOUMA, T., KINJO, K., OHYA, Y., & TAKISHITA, S. (2004) · Hypertension Research · doi:10.1291/hypres.27.835 · Cited by 167
Higgins, P., Dawson, J., Lees, K. R., McArthur, K., Quinn, T. J., & Walters, M. R. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00277.x · Cited by 164
Reduced Glomerular Function and Prevalence of Gout: NHANES 2009–10
Krishnan, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050046 · Cited by 159
The Epidemiology of Uric Acid and Fructose
Rho, Y. H., Zhu, Y., & Choi, H. K. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.004 · Cited by 156
Chuang, S., Lee, S.-C., Hsieh, Y.-T., & Pan, W. (2011) · PubMed · Cited by 141
Effects of acute and chronic l -arginine treatment in experimental hyperuricemia
Sánchez‐Lozada, L. G., Tapia, E., López-Molina, R., Nepomuceno‐Mejía, T., Soto, V., Ávila-Casado, C., Nakagawa, T., Johnson, R. J., Herrera-Acosta, J., & Franco, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2006 · Cited by 139
Self-citationEncyclopedia of Molecular Mechanisms of Disease
Läng, F. (2009) · Springer eBooks · doi:10.1007/978-3-540-29676-8 · Cited by 137
Zhang, M., Solomon, D. H., Desai, R. J., Kang, E. H., Liu, J., Neogi, T., & Kim, S. C. (2018) · Circulation · doi:10.1161/circulationaha.118.033992 · Cited by 137
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes
Sluijs, I., Holmes, M. V., van der Schouw, Y. T., Beulens, J. W. J., Asselbergs, F. W., Huerta, J. M., Palmer, T., Arriola, L., Balkau, B., Barricarte, A., et al. (2015) · Diabetes · doi:10.2337/db14-0742 · Cited by 131
Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
Rajendra, N. S., Ireland, S., Casella, G., Belch, J. J. F., Lang, C. C., & Struthers, A. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.052 · Cited by 131
Hyperuricemia and Incident Heart Failure
Krishnan, E. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.797662 · Cited by 127
Liu, Z., Que, S., Zhou, L., & Zheng, S. (2015) · Scientific Reports · doi:10.1038/srep14325 · Cited by 127
Allopurinol and Cardiovascular Outcomes in Adults With Hypertension
MacIsaac, R. L., Salatzki, J., Higgins, P., Walters, M. R., Padmanabhan, S., Dominiczak, A. F., Touyz, R. M., & Dawson, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06344 · Cited by 124
Elevated Uric Acid Increases the Risk for Acute Kidney Injury
Lapsia, V., Johnson, R. J., Dass, B., Shimada, M., Kambhampati, G., Ejaz, N. I., Arif, A. A., & Ejaz, A. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.06.021 · Cited by 119
Self-citationAssociation between serum uric acid level and metabolic syndrome components
Nejatinamini, S., Ataie‐Jafari, A., Qorbani, M., Nikoohemat, S., Kelishadi, R., Asayesh, H., & Hosseini, S. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0200-z · Cited by 118
McMullan, C. J., Borgi, L., Fisher, N. D. L., Curhan, G. C., & Forman, J. P. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10771016 · Cited by 113
Prasad, M., Matteson, E. L., Herrmann, J., Gulati, R., Rihal, C. S., Lerman, L. O., & Lerman, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08436 · Cited by 110
Renal effects of angiotensin II receptor blockade in normotensive subjects
Burnier, M., Roch‐Ramel, F., & Brunner, H. R. (1996) · Kidney International · doi:10.1038/ki.1996.268 · Cited by 107
Borghi, C., Tubach, F., De Backer, G., Dallongeville, J., Guallar, E., Medina, J., Perk, J., Roy, C., Banegas, J. R., Rodriguez-Artalejo, F., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.05.044 · Cited by 102
Self-citationCicero, A. F. G., Rosticci, M., Fogacci, F., Grandi, E., D’Addato, S., & Borghi, C. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.07.026 · Cited by 99
Self-citationSun, H., Pei, D., Lue, K., & Chen, Y.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143786 · Cited by 98
Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Brighetti, G., Zeni, P., & Zardini, P. (2002) · American Heart Journal · doi:10.1067/mhj.2002.122122 · Cited by 97
Could uric acid have a pathogenic role in pre-eclampsia?
Martin, A. C., & Brown, M. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.125 · Cited by 97
The association between hyperuricemia, left atrial size and new-onset atrial fibrillation
Chao, T., Hung, C., Chen, S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.067 · Cited by 90
Asymptomatic hyperuricemia: is it time to intervene?
Paul, B. J., Anoopkumar, K., & Krishnan, V. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3851-y · Cited by 90
Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis
Qu, L., Jiang, H., & Chen, J. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1243803 · Cited by 84
Sakai, H., Tsutamoto, T., Tsutsui, T., Tanaka, T., Ishikawa, C., & Horie, M. (2006) · Circulation Journal · doi:10.1253/circj.70.1006 · Cited by 83
Dai, X., Yuan, J., Yao, P., Yang, B., Gui, L., Zhang, X., Guo, H., Wang, Y., Chen, W., Wei, S., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9829-4 · Cited by 82
Gunawardhana, L., McLean, L., Punzi, H. A., Hunt, B., Palmer, R. N., Whelton, A., & Feig, D. I. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006683 · Cited by 78
Management of hyperuricemia in asymptomatic patients: A critical appraisal
Brucato, A. L., Cianci, F., & Carnovale, C. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.01.001 · Cited by 78
Baillie, J. K., Bates, M. G. D., Thompson, A. A. R., Waring, W. S., Partridge, R. W., Schnopp, M. F., Simpson, A., Gulliver-Sloan, F., Maxwell, S. R. J., & Webb, D. J. (2007) · CHEST Journal · doi:10.1378/chest.06-2235 · Cited by 77
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
Levy, G. D., Rashid, N., Niu, F., & Cheetham, T. C. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131159 · Cited by 75
Lin, T.-C., Hung, L., Chen, Y.-C., Lo, W., Lin, C. H., Tam, K., & Wu, M. (2019) · Medicine · doi:10.1097/md.0000000000016311 · Cited by 68
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension
Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., & Dawson, J. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03953 · Cited by 67
The association between serum uric acid level and coronary artery disease
Deveci, O. S., Kabakçı, G., Okutucu, S., Tülümen, E., Aksoy, H., Kaya, E. B., Evranos, B., Aytemir, K., Tokgözoğlu, L. S., & Oto, A. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02263.x · Cited by 65
Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension
Sedaghat, S., Hoorn, E. J., van Rooij, F. J. A., Albert Hofman, D., Franco, O. H., Witteman, J. C. M., & Dehghan, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076827 · Cited by 64
Shimizu, T., Yoshihisa, A., Kanno, Y., Takiguchi, M., Sato, A., Miura, S., Nakamura, Y., Yamauchi, H., Owada, T., Abe, S., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00533.2015 · Cited by 62
Hyperuricemia: a novel old disorder—relationship and potential mechanisms in heart failure
Borghi, C., Palazzuoli, A., Landolfo, M., & Cosentino, E. R. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09869-z · Cited by 59
Self-citationJuraschek, S. P., Kovell, L. C., Miller, E. R., & Gelber, A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056546 · Cited by 57
Singh, J. A., & Yu, S. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1111-1 · Cited by 48
Tani, S., Nagao, K., & Hirayama, A. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0349-8 · Cited by 47
Allopurinol and the risk of stroke in older adults receiving medicare
Singh, J. A., & Yu, S. (2016) · BMC Neurology · doi:10.1186/s12883-016-0692-2 · Cited by 43
Başar, N., Şen, N., Özcan, F., Erden, G., Kanat, S., Sökmen, E., İşleyen, A., Yüzgeçer, H., Özlü, M. F., Yıldırımkaya, M., et al. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318214ebaf · Cited by 40
Self-citationOda, E. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0386-2 · Cited by 40
Sun, D., Li, S., Zhang, X., Fernandez, C., Chen, W., Srinivasan, S. R., & Berenson, G. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089696 · Cited by 39
Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis
Song, M., Li, N., Yao, Y., Wang, K., Yang, J., Cui, Q., Geng, B., Chen, J., Wang, Y., Cheng, W., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14337 · Cited by 38
Kim, H., Kim, S., Choi, A. R., Kim, S., Choi, H. Y., Kim, H. J., & Park, H. C. (2017) · Medicine · doi:10.1097/md.0000000000006565 · Cited by 37
Meng, J., Li, Y., Yuan, X., & Lu, Y. (2016) · Rheumatology International · doi:10.1007/s00296-016-3612-2 · Cited by 35
Yokota, T., Fukushima, A., Kinugawa, S., Okumura, T., Murohara, T., & Tsutsui, H. (2018) · International Heart Journal · doi:10.1536/ihj.17-560 · Cited by 33
Piepoli, M. F., Salvioni, E., Corrà, U., Doni, F., Bonomi, A., Gioia, R. L., Limongelli, G., Paolillo, S., Sinagra, G., Scardovi, A. B., et al. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.11.003 · Cited by 31
Tian, Y., Chen, K., Xie, Z., Fang, Y., Wang, H., Nie, Y., Hu, D., & Mu, Y. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0059-4 · Cited by 29
Segal, M. S., Srinivas, T. R., Mohandas, R., Shuster, J. J., Wen, X., Whidden, E. M., Tantravahi, J., & Johnson, R. J. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.05.009 · Cited by 28
Self-citationBorghi, C., Rodríguez‐Artalejo, F., Backer, G. D., Dallongeville, J., Medina, J., Güallar, E., Perk, J., Banegas, J. R., Tubach, F., Roy, C., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001078 · Cited by 28
Self-citationHyperuricemia and uncontrolled hypertension in treated hypertensive patients
Cho, J., Kim, C., Kang, D. R., & Park, J. B. (2016) · Medicine · doi:10.1097/md.0000000000004177 · Cited by 25
He, S.-J., Chan, C., Xie, Z., Shi, D., Hu, X., Li, H., Wang, D. Y. Q., Wang, M., & Bai, Y. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1214261 · Cited by 25
Singh, J. A., & Yu, S. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209046 · Cited by 24
Association of Hyperuricemia With Conventional Cardiovascular Risk Factors in Elderly Patients
Marotta, T., Liccardo, M., Schettini, F., Verde, F., & Ferrara, A. L. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12434 · Cited by 22
Boyle, J. A., McKiddie, M. T., Buchanan, K. D., GRAY, H. W. J. M., Jackson, I. M., & Buchanan, W. W. (1969) · Annals of the Rheumatic Diseases · doi:10.1136/ard.28.4.374 · Cited by 22
Gout, not hyperuricemia alone, impairs left ventricular diastolic function
Lin, J.-C., Lin, C., Chen, M., Chang, P., Chang, S., Chung, C., & Pan, K. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0842-8 · Cited by 21
Elizalde-Barrera, C. I., Estrada‐García, T., Lozano-Nuevo, J. J., et al. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817732731 · Cited by 20
(2014) · PubMed
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationHyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
Drozdz, D., Alvarez-Pitti, J., Wójcik, M., Borghi, C., Gabbianelli, R., Mazur, A., Herceg-Čavrak, V., Lopez-Valcarcel, B. G., Brzeziński, M., Lurbe, E., et al. (2021) · Nutrients · doi:10.3390/nu13114176 · Cited by 409
Self-citationTherapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Metadata
- Authors
- Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P.
- Venue
- European Journal of Internal Medicine
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 80
- Pages
- 1-11
- ISSN
- 0953-6205 (ISSN-L)
- OpenAlex
- W3046126074
- Cited by
- 435
- References
- 126
- FWCI
- 23.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.